Association between admission haematocrit and mortality among men with acute ischaemic stroke

Jason J. Sico, Laura J. Myers, Brenda J. Fenton, John Concato, Linda Williams, Dawn Bravata

Research output: Contribution to journalArticle

Abstract

Objective: Anaemia is associated with higher mortality among patients with non-stroke cardiovascular conditions; less is known regarding the relationship between anaemia and mortality among patients with acute ischaemic stroke. Methods: Medical records were abstracted for n=3965 veterans from 131 Veterans Health Administration facilities who were admitted with ischaemic stroke in fiscal year 2007. Haematocrit values within 24 hours of admission were classified as ≤27%, 28%-32%, 33%-37%, 38%-42%, 43%-47% or ≥48%. Multivariate logistic regression was used to examine the relationship between anaemia and in-hospital, 30-day, 6-month and 1-year mortality, adjusting for age, medical comorbidities, modified Acute Physiology and Chronic Health Evaluation-III and stroke severity. Impact factors were calculated to standardise comparisons between haematocrit tier and other covariates. Results: Among n=3750 patients included in the analysis, the haematocrit values were ≤27% in 2.1% (n=78), 28%-32% in 6.2% (n=234), 33%-37% in 17.9% (n=670), 38%-42% in 36.4% (n=1366), 43%-47% in 28.2% (n=1059) and ≥48% in 9.1% (n=343). Patients with haematocrit ≤27%, compared with patients in the 38%-42% range, were more likely to have died across all follow-up intervals, with statistically significant adjusted ORs (aORs) ranging from 2.5 to 3.5. Patients with polycythaemia (ie, haematocrit ≥48%) were at increased risk of in-hospital mortality (aOR=2.9; 95% CI 1.4 to 6.0), compared with patients with mid-range admission haematocrits. Pronounced differences between patients receiving and not receiving blood transfusion limited our ability to perform a propensity analysis. Impact factors in the 1-year mortality model were 0.46 (severe anaemia), 0.06 (cancer) and 0.018 (heart disease). Conclusions: Anaemia is independently associated with an increased risk of death throughout the first year post stroke; high haematocrit is associated with early poststroke mortality. Severe anaemia is associated with 1-year mortality to a greater degree than cancer or heart disease. These data cannot address the question of whether interventions targeting anaemia might improve patient outcomes.

Original languageEnglish (US)
JournalStroke and Vascular Neurology
DOIs
StateAccepted/In press - Apr 24 2018
Externally publishedYes

Fingerprint

Hematocrit
Stroke
Anemia
Mortality
Heart Diseases
Veterans Health
Polycythemia
United States Department of Veterans Affairs
APACHE
Health Facilities
Veterans
Hospital Mortality
Blood Transfusion
Medical Records
Comorbidity
Neoplasms
Logistic Models

Keywords

  • anemia
  • hematocrit
  • ischemic stroke
  • mortality
  • polycythemia

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Clinical Neurology

Cite this

Association between admission haematocrit and mortality among men with acute ischaemic stroke. / Sico, Jason J.; Myers, Laura J.; Fenton, Brenda J.; Concato, John; Williams, Linda; Bravata, Dawn.

In: Stroke and Vascular Neurology, 24.04.2018.

Research output: Contribution to journalArticle

@article{32e3e73492d04233877001fa8c2d89b0,
title = "Association between admission haematocrit and mortality among men with acute ischaemic stroke",
abstract = "Objective: Anaemia is associated with higher mortality among patients with non-stroke cardiovascular conditions; less is known regarding the relationship between anaemia and mortality among patients with acute ischaemic stroke. Methods: Medical records were abstracted for n=3965 veterans from 131 Veterans Health Administration facilities who were admitted with ischaemic stroke in fiscal year 2007. Haematocrit values within 24 hours of admission were classified as ≤27{\%}, 28{\%}-32{\%}, 33{\%}-37{\%}, 38{\%}-42{\%}, 43{\%}-47{\%} or ≥48{\%}. Multivariate logistic regression was used to examine the relationship between anaemia and in-hospital, 30-day, 6-month and 1-year mortality, adjusting for age, medical comorbidities, modified Acute Physiology and Chronic Health Evaluation-III and stroke severity. Impact factors were calculated to standardise comparisons between haematocrit tier and other covariates. Results: Among n=3750 patients included in the analysis, the haematocrit values were ≤27{\%} in 2.1{\%} (n=78), 28{\%}-32{\%} in 6.2{\%} (n=234), 33{\%}-37{\%} in 17.9{\%} (n=670), 38{\%}-42{\%} in 36.4{\%} (n=1366), 43{\%}-47{\%} in 28.2{\%} (n=1059) and ≥48{\%} in 9.1{\%} (n=343). Patients with haematocrit ≤27{\%}, compared with patients in the 38{\%}-42{\%} range, were more likely to have died across all follow-up intervals, with statistically significant adjusted ORs (aORs) ranging from 2.5 to 3.5. Patients with polycythaemia (ie, haematocrit ≥48{\%}) were at increased risk of in-hospital mortality (aOR=2.9; 95{\%} CI 1.4 to 6.0), compared with patients with mid-range admission haematocrits. Pronounced differences between patients receiving and not receiving blood transfusion limited our ability to perform a propensity analysis. Impact factors in the 1-year mortality model were 0.46 (severe anaemia), 0.06 (cancer) and 0.018 (heart disease). Conclusions: Anaemia is independently associated with an increased risk of death throughout the first year post stroke; high haematocrit is associated with early poststroke mortality. Severe anaemia is associated with 1-year mortality to a greater degree than cancer or heart disease. These data cannot address the question of whether interventions targeting anaemia might improve patient outcomes.",
keywords = "anemia, hematocrit, ischemic stroke, mortality, polycythemia",
author = "Sico, {Jason J.} and Myers, {Laura J.} and Fenton, {Brenda J.} and John Concato and Linda Williams and Dawn Bravata",
year = "2018",
month = "4",
day = "24",
doi = "10.1136/svn-2018-000149",
language = "English (US)",
journal = "Stroke and Vascular Neurology",
issn = "2059-8688",
publisher = "BMJ Publishing Group",

}

TY - JOUR

T1 - Association between admission haematocrit and mortality among men with acute ischaemic stroke

AU - Sico, Jason J.

AU - Myers, Laura J.

AU - Fenton, Brenda J.

AU - Concato, John

AU - Williams, Linda

AU - Bravata, Dawn

PY - 2018/4/24

Y1 - 2018/4/24

N2 - Objective: Anaemia is associated with higher mortality among patients with non-stroke cardiovascular conditions; less is known regarding the relationship between anaemia and mortality among patients with acute ischaemic stroke. Methods: Medical records were abstracted for n=3965 veterans from 131 Veterans Health Administration facilities who were admitted with ischaemic stroke in fiscal year 2007. Haematocrit values within 24 hours of admission were classified as ≤27%, 28%-32%, 33%-37%, 38%-42%, 43%-47% or ≥48%. Multivariate logistic regression was used to examine the relationship between anaemia and in-hospital, 30-day, 6-month and 1-year mortality, adjusting for age, medical comorbidities, modified Acute Physiology and Chronic Health Evaluation-III and stroke severity. Impact factors were calculated to standardise comparisons between haematocrit tier and other covariates. Results: Among n=3750 patients included in the analysis, the haematocrit values were ≤27% in 2.1% (n=78), 28%-32% in 6.2% (n=234), 33%-37% in 17.9% (n=670), 38%-42% in 36.4% (n=1366), 43%-47% in 28.2% (n=1059) and ≥48% in 9.1% (n=343). Patients with haematocrit ≤27%, compared with patients in the 38%-42% range, were more likely to have died across all follow-up intervals, with statistically significant adjusted ORs (aORs) ranging from 2.5 to 3.5. Patients with polycythaemia (ie, haematocrit ≥48%) were at increased risk of in-hospital mortality (aOR=2.9; 95% CI 1.4 to 6.0), compared with patients with mid-range admission haematocrits. Pronounced differences between patients receiving and not receiving blood transfusion limited our ability to perform a propensity analysis. Impact factors in the 1-year mortality model were 0.46 (severe anaemia), 0.06 (cancer) and 0.018 (heart disease). Conclusions: Anaemia is independently associated with an increased risk of death throughout the first year post stroke; high haematocrit is associated with early poststroke mortality. Severe anaemia is associated with 1-year mortality to a greater degree than cancer or heart disease. These data cannot address the question of whether interventions targeting anaemia might improve patient outcomes.

AB - Objective: Anaemia is associated with higher mortality among patients with non-stroke cardiovascular conditions; less is known regarding the relationship between anaemia and mortality among patients with acute ischaemic stroke. Methods: Medical records were abstracted for n=3965 veterans from 131 Veterans Health Administration facilities who were admitted with ischaemic stroke in fiscal year 2007. Haematocrit values within 24 hours of admission were classified as ≤27%, 28%-32%, 33%-37%, 38%-42%, 43%-47% or ≥48%. Multivariate logistic regression was used to examine the relationship between anaemia and in-hospital, 30-day, 6-month and 1-year mortality, adjusting for age, medical comorbidities, modified Acute Physiology and Chronic Health Evaluation-III and stroke severity. Impact factors were calculated to standardise comparisons between haematocrit tier and other covariates. Results: Among n=3750 patients included in the analysis, the haematocrit values were ≤27% in 2.1% (n=78), 28%-32% in 6.2% (n=234), 33%-37% in 17.9% (n=670), 38%-42% in 36.4% (n=1366), 43%-47% in 28.2% (n=1059) and ≥48% in 9.1% (n=343). Patients with haematocrit ≤27%, compared with patients in the 38%-42% range, were more likely to have died across all follow-up intervals, with statistically significant adjusted ORs (aORs) ranging from 2.5 to 3.5. Patients with polycythaemia (ie, haematocrit ≥48%) were at increased risk of in-hospital mortality (aOR=2.9; 95% CI 1.4 to 6.0), compared with patients with mid-range admission haematocrits. Pronounced differences between patients receiving and not receiving blood transfusion limited our ability to perform a propensity analysis. Impact factors in the 1-year mortality model were 0.46 (severe anaemia), 0.06 (cancer) and 0.018 (heart disease). Conclusions: Anaemia is independently associated with an increased risk of death throughout the first year post stroke; high haematocrit is associated with early poststroke mortality. Severe anaemia is associated with 1-year mortality to a greater degree than cancer or heart disease. These data cannot address the question of whether interventions targeting anaemia might improve patient outcomes.

KW - anemia

KW - hematocrit

KW - ischemic stroke

KW - mortality

KW - polycythemia

UR - http://www.scopus.com/inward/record.url?scp=85050583542&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050583542&partnerID=8YFLogxK

U2 - 10.1136/svn-2018-000149

DO - 10.1136/svn-2018-000149

M3 - Article

AN - SCOPUS:85050583542

JO - Stroke and Vascular Neurology

JF - Stroke and Vascular Neurology

SN - 2059-8688

ER -